<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Microbiology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>6</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Using recombinant Chlamydia trachomatis OMP2 as antigen in diagnostic ELISA test</title>
    <FirstPage>8</FirstPage>
    <LastPage>13</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mahdieh</FirstName>
        <LastName>Javaherian</LastName>
        <affiliation locale="en_US">Microbiology Department, Islamic Azad University, Qom, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zarin</FirstName>
        <LastName>Sharifnia</LastName>
        <affiliation locale="en_US">Cellular and Molecular Biology Research center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Robabeh</FirstName>
        <LastName>Taheripanah</LastName>
        <affiliation locale="en_US">Fertility and Infertility Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mojgan</FirstName>
        <LastName>Bandepour</LastName>
        <affiliation locale="en_US">Cellular and Molecular Biology Research center, Shahid Beheshti University of Medical Sciences, Tehran, Iran AND Biotechnology Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Soleimani</LastName>
        <affiliation locale="en_US">Microbiology Department, Islamic Azad University, Qom, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Bahram</FirstName>
        <LastName>Kazemi</LastName>
        <affiliation locale="en_US">Cellular and Molecular Biology Research center, Shahid Beheshti University of Medical Sciences, Tehran, Iran AND Biotechnology Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: The obligate intracellular bacterium Chlamydia trachomatis causes sexually transmissible diseases in human. Timely and sensitive detection of this pathogen is very important. There are many cross-reactions in bacteriological and serological methods in detection of this type of pathogens. The aim of this study was to achieve a more specific antigen for serological tests.
Materials and Methods: Blood samples were taken from 192 women with suspected chlamydial infection and sera were isolated. ELISA plate wells were coated with recombinant C. trachomatis OMP2 as antigen. Cut-off system was determined with 40 negative sera. The final results of this research were compared with Euroimmun commercial kit.
Results: The ELISA system cut-off was calculated at 0.27 using negative sera samples. ODs of positive samples were higher than 0.27 and negative samples were lower than it. We obtained 30 samples (15.62%) as positive and 162 cases (84.37%) as negative. Sensitivity and specificity of the recombinant antigen were 90% and 86%, respectively. This antigen showed no cross-reactivity with sera of patients infected with Hydatid cyst, HCV, Epstein barr virus, HBV, Helicobacter pylori, Toxo- plasma gondii, Cytomegalovirus, Mycoplasma, Measles and Varicella zoster virus.
Conclusion: The sensitivity and specificity of rOMP2 in ELISA for detection of C. trachomatis were 90% and 86%, respec- tively. Though the sensitivity was higher than results of Euroimmun commercial kit, its specificity was calculated lower than reference kit.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/474</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/474/250</pdf_url>
  </Article>
</Articles>
